Literature DB >> 18409017

A PCR based method to construct small interference RNA expression vectors.

Zhiyong Zhang1, Lihui Han, Xiaohong Liang, Lili Cao, Wensheng Sun.   

Abstract

Small interference RNAs (siRNA) have been shown to be useful in the field of gene therapy and gene function studies. As a siRNA expression vector, pSilencer employ RNA polymerase III promoters and could stably produce siRNA for weeks. But once one siRNA sequence was inserted into the pSilencer vector, the other siRNA sequence will hardly be reconstructed, because the site of siRNA production has been occupied and difficult to be changed, so it is not suitable for screen of effective siRNA sequence. To solve this problem, we constructed the subclone pSilcencer329, which generated from pSilencer3.1, then developed a PCR based method of constructing siRNA expression vectors, and generated pSilencerBCL2L2 recombinants efficiently. This method was proven to be effective, reliable, and less expensive, and thus will be of great help in regular gene silencing studies, and will be especially suitable for large scale gene function analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18409017     DOI: 10.1007/s11033-008-9248-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  12 in total

Review 1.  RNA interference and the use of small interfering RNA to study gene function in mammalian systems.

Authors:  I Bantounas; L A Phylactou; J B Uney
Journal:  J Mol Endocrinol       Date:  2004-12       Impact factor: 5.098

2.  Guidelines for the selection of effective short-interfering RNA sequences for functional genomics.

Authors:  Kumiko Ui-Tei; Yuki Naito; Kaoru Saigo
Journal:  Methods Mol Biol       Date:  2007

Review 3.  On the art of identifying effective and specific siRNAs.

Authors:  Yi Pei; Thomas Tuschl
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

Review 4.  Gene silencing by small regulatory RNAs in mammalian cells.

Authors:  Michaela Scherr; Matthias Eder
Journal:  Cell Cycle       Date:  2007-02-05       Impact factor: 4.534

Review 5.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

6.  A protocol for designing siRNAs with high functionality and specificity.

Authors:  Amanda Birmingham; Emily Anderson; Kevin Sullivan; Angela Reynolds; Queta Boese; Devin Leake; Jon Karpilow; Anastasia Khvorova
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

8.  Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.

Authors:  G Carvalho; C Fabre; T Braun; J Grosjean; L Ades; F Agou; E Tasdemir; S Boehrer; A Israel; M Véron; P Fenaux; G Kroemer
Journal:  Oncogene       Date:  2006-10-16       Impact factor: 9.867

9.  Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway.

Authors:  Yulei Du; Fang Yin; Changjiang Liu; Shengjuan Hu; Jun Wang; Huahong Xie; Liu Hong; Daiming Fan
Journal:  Biochem Biophys Res Commun       Date:  2006-05-08       Impact factor: 3.575

10.  Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.

Authors:  Qing Luo; Quan Kang; Wen-Xin Song; Hue H Luu; Xiaoji Luo; Naili An; Jinyong Luo; Zhong-Liang Deng; Wei Jiang; Hong Yin; Jin Chen; Katie A Sharff; Ni Tang; Erwin Bennett; Rex C Haydon; Tong-Chuan He
Journal:  Gene       Date:  2007-03-23       Impact factor: 3.688

View more
  1 in total

1.  Characterization of the specific and sustained GH1 expression induced by rAAV2/1 in normal adult male rats.

Authors:  Ying Qin; Ya-Ping Tian
Journal:  Mol Biol Rep       Date:  2010-03-04       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.